Research

Dr. Adair is a world-leading scientist whose research focuses on isolating stem and immune cell populations, genetically modifying them with cutting-edge CRISPR technology, and then delivering them to patients as a "living drug" as well as using nanoparticles as a platform to deliver gene therapy to patient cells. She is an internationally recognized expert in using these approaches to develop novel treatments for genetic, malignant, and infectious diseases as well as in the advancement of gene therapy vector technologies and manufacturing.